Antibiotic study in cystic fibrosis: measuring drug levels
NCT ID NCT04460586
First seen May 10, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study looked at how the antibiotic omadacycline behaves in the bodies of 9 adults with cystic fibrosis. Participants received the drug by IV and by mouth so researchers could measure peak levels, total exposure, and absorption. The goal was to gather information for better dosing, not to treat the disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Southern California
Los Angeles, California, 90089, United States
Conditions
Explore the condition pages connected to this study.